Summit is listed on AIM, a market of the London Stock Exchange and the NASDAQ Global Market.  More detailed share information is provided below.

SHARE INFORMATION

Issued share capital: 70,629,352 Ordinary Shares of 1p nominal value

The percentage of Ordinary Shares not being held in public hands is 28.3%.
Shares held in treasury: Nil Ordinary shares.
There are no restrictions on the transfer of Ordinary Shares in the Company.

AIM Listing

Shares Listed: Ordinary Shares
Ticker: SUMM
Index FTSE AIM All Share
Sector: Pharmaceutical & Biotechnology

 

NASDAQ Listing

Shares Listed: American Depositary Shares (ADS)
Ticker: SMMT
Market: NASDAQ Global Market
Depositary Bank: Bank of New York Mellon

Each ADS represents five Ordinary Shares.

Information correct as at 17 November 2017

 

MAJOR SHAREHOLDERS

Summit had been notified of the following holdings of more than 3% or more of the issued share capital of the Company

Name Number of Shares
Lansdowne Partners Limited 19,060,500 26.9%
Robert Keith 4,294,816 6.1%
Point72 Asset Management 4,006,155 5.7%
Hargreave Hale Limited 2,921,500 4.1%

Information reviewed on 17 November 2017